David H. Randle
- Molecular Biology top 5%
- Oncology top 2%
- Cancer Research top 10%
- Cell Biology top 10%
- Biotechnology top 5%
- Co-authors
- Charles J. SherrMartine F. RousselTakehiko KamijoFrédérique ZindyJohn L. ClevelandChristine M. EischenSara M. BodnerEsther van de Kamp
- Topics
- Cancer-related Molecular Pathways (5 papers)Cancer Research and Treatments (3 papers)Receptor Mechanisms and Signaling (2 papers)
- Partner nations
- United States
In The Last Decade
David H. Randle
9 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 1.5k
- Oncology 1.3k
- Cancer Research 268
- Cell Biology 208
- Biotechnology 189
Countries citing papers authored by David H. Randle
This map shows the geographic impact of David H. Randle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Randle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Randle more than expected).
Fields of papers citing papers by David H. Randle
This network shows the impact of papers produced by David H. Randle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Randle. The network helps show where David H. Randle may publish in the future.
Co-authorship network of co-authors of David H. Randle
This figure shows the co-authorship network connecting the top 25 collaborators of David H. Randle. A scholar is included among the top collaborators of David H. Randle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Randle. David H. Randle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 65 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 70 | |
| 5 | 93 | |
| 6 | 92 | |
| 7 | 301 | |
| 8 | Tumor spectrum in ARF-deficient mice. | 279 |
| 9 | Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalizationbreakdown → | 1034 |
About David H. Randle
David H. Randle is a scholar working on Biotechnology, Oncology and Molecular Biology, having authored 9 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Cancer Research and Treatments (3 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Oncology (1.3k citations), Molecular Biology (1.5k citations) and Biotechnology (189 citations). David H. Randle has collaborated with scholars based in United States. Frequent co-authors include Charles J. Sherr, Martine F. Roussel, Takehiko Kamijo, Frédérique Zindy, John L. Cleveland, Christine M. Eischen, Sara M. Bodner, Esther van de Kamp, Jerold E. Rehg and C J Sherr. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.